About
Anti-CD180 Monoclonal Antibodies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodySeattle/Pacific Northwest
Funding History (1)
D
Feb 3, 2023
Locations (1)
Headquarters
Seattle, WA, United States
Map
Loading map...
Anti-CD180 Monoclonal Antibodies
Loading map...